Clinical Outcomes after Intravenous Alteplase in Elderly Patients with Acute Ischaemic Stroke: A Retrospective Analysis of Patients Treated at a Tertiary Neurology Centre in England from 2013 to 2018
Intravenous thrombolysis with alteplase within 4.5 hours from symptom onset is a well-established treatment of acute ischaemic stroke (AIS). The aim was to compare alteplase for AIS between patients aged >80 and ≤80 years in our registry data, from 2013 to 2018. Mechanical thrombectomy cases were...
Saved in:
| Main Authors: | Xuya Huang, Phillip Nash, Vafa Alakbarzade, Brian Clarke, Anthony C. Pereira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Stroke Research and Treatment |
| Online Access: | http://dx.doi.org/10.1155/2021/3738017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial
by: Yongjun Wang, et al. -
Efficacy, Influencing Factors, and Safety of Alteplase Intravenous Thrombolysis in Patients with Acute Ischemic Stroke Combined with Atrial Fibrillation
by: Yongyin Zhang, et al.
Published: (2022-01-01) -
A comparative study of thrombolysis in cases of prosthetic mitral valve replacement dysfunction between intravenous alteplase and intravenous urokinase
by: Maulik Sharma, et al.
Published: (2025-01-01) -
Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases
by: Eijirou Tanaka, et al.
Published: (2025-01-01) -
Abstract 073: Thrombectomy Alone Versus Bridging Intravenous Alteplase in A US Population: Regression Discontinuity Analysis
by: Ngoc Mai Le, et al.
Published: (2023-11-01)